BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38475929)

  • 1. Homocysteine potentiates amyloid
    Carey A; Parodi-Rullan R; Vazquez-Torres R; Canepa E; Fossati S
    Aging Cell; 2024 May; 23(5):e14106. PubMed ID: 38358083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurovascular defects and faulty amyloid-β vascular clearance in Alzheimer's disease.
    Sagare AP; Bell RD; Zlokovic BV
    J Alzheimers Dis; 2013; 33 Suppl 1(0 1):S87-100. PubMed ID: 22751174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shenqi Yizhi prescription prevents AβO-induced memory impairment in mice by regulating the contractility of brain pericytes.
    Zhao P; Cheng P; Wang J; Zhu G; Wang X
    Phytomedicine; 2024 Jul; 129():155639. PubMed ID: 38669966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The contribution of β-amyloid, Tau and α-synuclein to blood-brain barrier damage in neurodegenerative disorders.
    Wu YC; Bogale TA; Koistinaho J; Pizzi M; Rolova T; Bellucci A
    Acta Neuropathol; 2024 Feb; 147(1):39. PubMed ID: 38347288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pericytes in Alzheimer's disease: Key players and therapeutic targets.
    Zhang Y; Mu BR; Ran Z; Zhu T; Huang X; Yang X; Wang DM; Ma QH; Lu MH
    Exp Neurol; 2024 May; 379():114825. PubMed ID: 38777251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precise Modulation of Pericyte Dysfunction by a Multifunctional Nanoprodrug to Ameliorate Alzheimer's Disease.
    Yang P; Li Y; Qian K; Zhou L; Cheng Y; Wu J; Xu M; Wang T; Yang X; Mu Y; Liu X; Zhang Q
    ACS Nano; 2024 Jun; 18(22):14348-14366. PubMed ID: 38768086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gliovascular transcriptional perturbations in Alzheimer's disease reveal molecular mechanisms of blood brain barrier dysfunction.
    İş Ö; Wang X; Reddy JS; Min Y; Yilmaz E; Bhattarai P; Patel T; Bergman J; Quicksall Z; Heckman MG; Tutor-New FQ; Can Demirdogen B; White L; Koga S; Krause V; Inoue Y; Kanekiyo T; Cosacak MI; Nelson N; Lee AJ; Vardarajan B; Mayeux R; Kouri N; Deniz K; Carnwath T; Oatman SR; Lewis-Tuffin LJ; Nguyen T; ; Carrasquillo MM; Graff-Radford J; Petersen RC; Jr Jack CR; Kantarci K; Murray ME; Nho K; Saykin AJ; Dickson DW; Kizil C; Allen M; Ertekin-Taner N
    Nat Commun; 2024 Jun; 15(1):4758. PubMed ID: 38902234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of pericyte in ocular vascular diseases.
    Shi LJ; Ge H; Ye F; Li X; Jiang Q
    J Biomed Res; 2024 Apr; ():1-10. PubMed ID: 38808554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Visual Approach for Inducing Dolichoectasia in Mice to Model Large Vessel-Mediated Cerebrovascular Dysfunction.
    Simpson D; Morrone CD; Wear D; Gutierrez J; Yu WH
    J Vis Exp; 2024 May; (207):. PubMed ID: 38829135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease.
    Yamazaki Y; Kanekiyo T
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28902142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological changes within the cerebral vasculature in Alzheimer's disease: New perspectives.
    Fisher RA; Miners JS; Love S
    Brain Pathol; 2022 Nov; 32(6):e13061. PubMed ID: 35289012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid β oligomer induces cerebral vasculopathy via pericyte-mediated endothelial dysfunction.
    Chen S; Guo D; Zhu Y; Xiao S; Xie J; Zhang Z; Hu Y; Huang J; Ma X; Ning Z; Cao L; Cheng J; Tang Y
    Alzheimers Res Ther; 2024 Mar; 16(1):56. PubMed ID: 38475929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of early pericyte loss and vascular amyloidosis in Alzheimer's disease retina.
    Shi H; Koronyo Y; Rentsendorj A; Regis GC; Sheyn J; Fuchs DT; Kramerov AA; Ljubimov AV; Dumitrascu OM; Rodriguez AR; Barron E; Hinton DR; Black KL; Miller CA; Mirzaei N; Koronyo-Hamaoui M
    Acta Neuropathol; 2020 May; 139(5):813-836. PubMed ID: 32043162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysfunction of the blood-brain barrier in Alzheimer's disease: Evidence from human studies.
    Kurz C; Walker L; Rauchmann BS; Perneczky R
    Neuropathol Appl Neurobiol; 2022 Apr; 48(3):e12782. PubMed ID: 34823269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.
    Bell RD; Zlokovic BV
    Acta Neuropathol; 2009 Jul; 118(1):103-13. PubMed ID: 19319544
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.